APA (7th ed.) Citation

SD, P., & KL, K. (2000). The importance of quality-of-life endpoints in clinical trials to the practicing oncologist. Hematology/oncology clinics of North America, 14(4), 877. https://doi.org/10.1016/s0889-8588(05)70316-6

Chicago Style (17th ed.) Citation

SD, Passik, and Kirsh KL. "The Importance of Quality-of-life Endpoints in Clinical Trials to the Practicing Oncologist." Hematology/oncology Clinics of North America 14, no. 4 (2000): 877. https://doi.org/10.1016/s0889-8588(05)70316-6.

MLA (9th ed.) Citation

SD, Passik, and Kirsh KL. "The Importance of Quality-of-life Endpoints in Clinical Trials to the Practicing Oncologist." Hematology/oncology Clinics of North America, vol. 14, no. 4, 2000, p. 877, https://doi.org/10.1016/s0889-8588(05)70316-6.